Edition:
United States

Ventas Inc (VTR.N)

VTR.N on New York Stock Exchange

62.46USD
9 Dec 2016
Change (% chg)

$-0.15 (-0.24%)
Prev Close
$62.61
Open
$62.75
Day's High
$63.86
Day's Low
$62.33
Volume
401,441
Avg. Vol
570,903
52-wk High
$76.80
52-wk Low
$46.87

Latest Key Developments (Source: Significant Developments)

Kindred announces agreements with Ventas Inc
Monday, 14 Nov 2016 07:00am EST 

Kindred Healthcare Inc : Kindred Healthcare Inc - expect our exit from skilled nursing facility business to be accretive to earnings . Kindred Healthcare Inc - expect after-tax net proceeds from sale of assets will range from $100 million to $300 million after transaction costs . Kindred Healthcare Inc - expect to apply anticipated net proceeds to reduce funded debt . Kindred Healthcare Inc - will continue to operate ventas properties as it works to sell them to new owners/operators .Press release - kindred announces agreements with ventas facilitating strategic exit from skilled nursing facility business.  Full Article

Ventas reports agreements with Kindred Healthcare to facilitate Kindred's exit from the skilled nursing segment
Monday, 14 Nov 2016 06:59am EST 

Ventas Inc : Ventas Inc - Kindred expected to purchase 36 ventas skilled nursing facilities for $700 million . Upon sale of SNFS, Ventas is expected to record a gain of over $600 million . Ventas - Kindred to resell 36 purchased snfs as part of its exit from its entire snf business segment, which it expects to complete by year end 2017 . Ventas Inc - on or before April 30, 2018, all of Ventas-kindred assets will be consolidated into a single master lease between companies . Ventas Inc - Kindred expected to purchase 36 ventas skilled nursing facilities for $700 million .Ventas Inc - agreements with Kindred Healthcare to extend lease term to 2025 for all of Ventas's long term acute care hospitals.  Full Article

Ventas expects loan to be accretive to 2017 normalized funds
Wednesday, 5 Oct 2016 04:01pm EDT 

Ventas Inc : To provide secured debt financing of $700 million to unit of Ardent Health Services in connection with Ardent's agreement to buy LHP Hospital Group . Ventas issues secured debt financing commitment for ardent health services to merge with LHP Hospital Group, Inc. . Ventas expects loan to be accretive to 2017 normalized funds from operations on a leverage neutral basis .Expects to fund transaction using proceeds of asset sales and loan repayments, cash on hand and other capital sources.  Full Article

Ardent Health Services and LHP Hospital Group announce plans to merge
Wednesday, 5 Oct 2016 04:00pm EDT 

Ardent Health Services : Ardent Health Services and Lhp Hospital Group, Inc announce plans to merge . Terms of transaction were not disclosed . Under terms of agreement, co will assume LHP's management, operational responsibilities within each joint venture partnership . Ardent health services and LHP Hospital Group, Inc announce plans to merge .Transaction is not expected to impact day-to-day operations of affiliated hospitals.  Full Article

Ventas believes investigation by SEC is over
Monday, 26 Sep 2016 04:56pm EDT 

Ventas Inc : SEC investigation regarding co's former accounting firm's determination that it was not independent of Co completed with no action against Co . Believes investigation by SEC regarding Co's former registered public accounting firm has been completed - SEC filing . Says on Sept 21, Co received letter from SEC staff indicating that SEC staff has concluded investigation as to co related to matter Further company coverage: [VTR.N] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Care Capital Properties Q2 adjusted FFO per share $0.79
Thursday, 11 Aug 2016 07:32am EDT 

Care Capital Properties Inc : Q2 adjusted FFO per share $0.79 . Q2 FFO per share $0.77 . Care capital properties reports second quarter 2016 results . Sees FY 2016 adjusted FFO per share $2.92 to $2.98 . 2016 National Association of Real Estate Investment Trusts (NAREIT) FFO range is now expected to be between $2.85 and $2.91 per diluted common share . Raising its 2016 normalized FFO guidance range to $2.92 to $2.98 per diluted common share . Q2 FFO per share view $0.76 -- Thomson Reuters I/B/E/S . Raises 2016 guidance . 2016 NAREIT FFO range is now expected to be between $2.85 and $2.91 per diluted common share .FY2016 FFO per share view $2.93 -- Thomson Reuters I/B/E/S.  Full Article

Ventas issued and sold 10.2 mln shares of its common stock
Monday, 11 Jul 2016 04:32pm EDT 

Ventas Inc : Issued and sold 10. 2 million shares of its common stock, par value $0.25 per share - SEC filing .Ventas inc says expects to receive net proceeds from the offering of about $735.3 million after deducting its estimated expenses.  Full Article

Ventas announces pricing of common stock offering
Tuesday, 5 Jul 2016 09:01pm EDT 

Ventas Inc : Ventas announces pricing of common stock offering . J.P. Morgan is serving as sole underwriter for offering . Says offering 9 million common shares .Intends to use proceeds from offering to fund portion of $1.5 billion purchase price of real estate portfolio of Wexford Science & Technology.  Full Article

Ventas announces public offering of 9 mln shares of common stock
Tuesday, 5 Jul 2016 04:32pm EDT 

Ventas Inc : Ventas announces public offering of 9,000,000 shares of common stock . Company has also granted underwriter a 30-day option to purchase up to an additional 1.4 million shares of common stock .Intends to use net proceeds to fund portion of $1.5 billion purchase price of its pending acquisition of real estate portfolio of Wexford Science & Technology.  Full Article

Ventas to buy life science and medical real estate assets of Wexford Science
Tuesday, 5 Jul 2016 04:29pm EDT 

Ventas Inc : Total consideration for transaction is $1.5 billion plus assumption of $33 million of liabilities . Total consideration for 23 operating properties is $1.4 billion . Company is also acquiring nine development sites principally contiguous to existing assets . Transaction expected to be accretive in 2017 by $0.07 to $0.09 per share to normalized ffo . Definitive agreement to acquire substantially all of life science and medical real estate assets of wexford science & technology, llc .Wexford will continue to manage portfolio.  Full Article

BRIEF-Kindred announces agreements with Ventas Inc

* Kindred Healthcare Inc - expect our exit from skilled nursing facility business to be accretive to earnings